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Though the recent literature contains many 
favourable reports on the treatment of Tuberculosis 
cutis with preparations of calciferol, most of these 
studies appear to be based on merely clinical 
observations (1 -10) and few of them deal with the 
histological aspects of the disease and alterations 
in these arising as a result of treatment. 
Vachon and Feroldi (6), Kuske (11), and 
Freudenthal (12) have made observations on biopsy 
material from patients treated with calciferol and 
found that the tuberculous lesions are not rapidly 
or profoundly affected, at least in the earlier 
stages of therapy. 
In this study an effort has been made to 
follow the changes due to treatment in the 
pathological anatomy of the disease as assessed by 
the histological and clinical findings. Successive 
biopsies of comparable areas of the lesions under 
treatment provide a more accurate estimate of the 
mechanism of action of the drug and, in fact, it is 
only in the skin that such direct observation of the 
disease process in a single organ is so readily 
made. 
The histology at any given time, however, is 
obviously of somewhat restricted value in observing 
the details of a continous biological process, but it 
does provide a definite means of evaluating any 
ma for / 
2. 
major changes occurring in the area studied. The 
observed results can be interpreted only within the 
limits of the present available knowledge of the 
pathogensis of tuberculous lesions and of the various 
factors influencing their occurrence and fate. 
Considerable advantage results from the 
study of the disease in man as contrasted with 
experimental animals since it can be assumed that the 
evidence, although subject to personal evaluation, is 
in the nature of a direct observation not conditioned 
by any species difference. 
The picture becomes more complicated when the 
factors of local organ peculiarities, immunity, 
allergy and the nature of the bacillus come to be 
considered. The cellular reactions in tuberculosis 
arise by chemical stimulation of the tissues, the 
nature and severity of which determine the type 
of response. Tuberculosis cutis represents some 
phases of disease due to the tubercle bacillus and 
its products which produce chronic lesions capable 
of slow progress or regression with healing. The 
disease usually occurs in individuals possessing 
good general health and a significant degree of 
resistance to the tuberculous process. Toxaemia is 
not a feature, neither is the presence of active 
disease in other organs such as the lung, although 
there may be evidence of previous or quiescent lesions. 
The clinical form of the disease varies with the 
route/ 
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route of infection be it haematogenous, innoculation 
or from a subjacent focus and with the state and 
extent of the immune and allergic responses of the 
individual. (14) 
The nature of the bacillus warrants special 
consideration on account of the low grade activity 
which Griffith (15) (16) presumed to be due to 
degradation in the cutaneous tissues while Frimodt- 
Moller (17) thought that there were attenuated 
strains of the bacillus in lupus. 
The commonest clinical form is lupus vulgaris 
and in this organisms are not readily demonstrable 
by staining methods or by culture and animal 
innoculation of material from the lesions. 
Reaction on the part of the host appears to 
destroy the organisms making demonstration difficult 
especially in the later stages despite persistant 
histological features of the disease.. This is in 
keeping with the conclusions of Smithburn and Sabin 
(19) that the epithelioid cell follicles can arise 
as a chemical entity due to bacterial products in the 
presence of few, if any, viable organisms. 
Lupus vulgaris consists essentially of 
tuberculous granulomata in the dermis involved in some 
degree of fibrous tissue reaction and causing 
secondary changes in the epidermis. It is usually 
localised and tends to spread at the periphery and 
to show central areas of healing. 
Caseating areas favourable for bacterial 
proliferation/ 
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proliferation are uncommon in the skin, this probably 
being a local feature arising in the elaborate complex 
of infection due to the tubercle bacillus, and 
rendering difficult any comparison with lesions in 
other organs. 
Again healing in dermal tissues is slow and 
the metabolism of protein less than in other organs, 
Schoenheimer (20) finding little activity in the 
fixation of dietary nitrogen. 
In considering the effects of treatment it is 
important to remember that the fate of a tubercle 
may be quiescence, resolution, or activity, the 
changes of which may be slow and not readily apparent 
to clinical observation. 
This study covered a series of cases 
classified into two groups; cases of lupus vulgaris 
and cases of conditions commonly regarded as being of 
tuberculous origin. 
The drug has been administered orally and by 
local application over long periods with few toxic 
manifestations. The study of the cases extends over 
two years and assessment has been made of each 
individual to the time of writing with the reservation 
that further treatment of some, and periodic review 
all the,cases, will serve to determine long term 
results of the method of therapy. 
Some small use has been made of the recent 
device of imitation of molecules for experiments in 
the biological field by the study of granulomata 
produced/ 
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produced by synthetic pthioic acid in animal skin 
and of the effect of calciferol on these. This 
chemical, representing the most active granuloma 
producing element of the chemical fractions of the 
tubercle bacillus, is free of nitrogen and unlikely to 
produce reactions complicated by allergy. 
Experiments with this and similar compounds 
should provide a potential source of information on 
the mechanism of tubercle formation and perhaps 
a screening method for therapeutic substances. 
6s 
2. Historical Survey. 
Calciferol being a synthetic compound there 
is no extensive history of its use as a therapeutic 
agent. Vitamin D in the form of Codliver oil has a 
traditional value in the treatment of many forms of 
tuberculosis and is said to have been used by the 
fisherfolk and first advocated by Thomas Percival in 
1774. The literature contains many references to the 
beneficial results obtained (21) (22) (23) (24) (25) 
(26). 
The use of codliver oil in treating lupus 
vulgaris is attributed by Bicknell to Devergie of 
Paris in 1848 and to Emery in the same year when 
satisfactory results were obtained from intensive and 
prolonged dosage. Further recommendation came from 
Stelwagon in 1907 since when codliver has been 
consistently referred to in standard works on the 
disease (27) (28). 
A high intake of fat soluble vitamins 
including D is a feature of the Gerson and similar 
diets and of the nutritional regimes of many 
institutions engaged in the treatment of patients 
suffering from tuberculosis (29) (30) (31). 
In 1928 Shope (32) based a series of 
chemotherapeutic experiments on the observation that 
cholesterol tended to accumulate in tuberculous foci 
and that it might act as an adjuvant to the healing 
process. Irradiated cholesterol was regarded as 
definitely/ 
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definitely prolonging the lives of infected animals 
in one of these experiments. This was followed by 
Spies (33) finding that irradiated ergosterol 
produced marked calcification of the caseous 
and necrotic centres of tubercles in acute tuberculo- 
sis in rabbits while there was little tendency for 
calcium to precipitate in the absence of necrosis. 
Levaditi and Li Yuan Po (34) in the same year 
reported that irradiated ergosterol produced 
calcification in experimental tuberculosis and 
appeared to exert a favourable influence on the 
course of the lesions. These authors included in 
their paper an interesting discussion of the then 
available information on the effects due to vitamin D 
which could influence the various forms of tuberculosi 
and of the possible basis of action for these changes. 
These works raised the possibility of promoting 
healing and calcification of human lesions by means 
of one or other form of vitamin D, irradiated 
ergosterol being the most readily available 
concentrated product. 
Kramer et al (35) treated a series of children, 
one with skin tuberculosis and others with bone 
infections, over a period of a year using irradiated 
ergosterol and recorded that there was no detectable 
acceleration of the healing process. 
Credit for the systematic use of preparations 
of calciferol in skin tuberculosis must be 
attributed to the work of Charpy (36 -41), Dowling 
and/ 
technique (62) (63) (64). 
These irradiations are considered lethal to 
tubercle bacilli directly only to depths of 1.5. m.m. 
and to diminish the virulence up to 4 m.m. (65) so 
that the tubercles are subject to direct attack 
but difficult of access when situated in the deeper 
dermis. Vitamin D arising from the sterols in the 
irradiated skin is to be considered a factor in the 
promoting healing. Calciferol in large doses reaches 
a higher tissue concentration than can be achieved 
by irradiation but it appears sound to combine the 
treatments even if there is some likelihood tof toxic 




Calciferol is a sterol compound that has not 
been found in nature and is usually manufactured 
from a precursor,, ergosterol, the common source of 
which is yeast. These two, cholesterol and various 
animal and plant sterols, the sex hormones, 
strophanthin, bufoxtoxins and certain carcinogenic 
hydxrocarbons have a related chemical structure 
(66) (67) (68) 
TH 
Me. CN: CHMeCNflea 
Calciferol 
This basic chemical structure is stable and 
difficult to rupture except by strong methods of 
treatment (68). 
Ergosterol has a strong absorption band at 
305 -230 millimicrons leading to photochemical 








Suprasterol 1. Suprasterol 2. 
Wavelengths longer than 305 millimcrons can 
have similar effects/ 
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There are variations due to the quantity of 
irradiation and to the presence of solvents and of 
oxygen (69). 
Calciferol can also be produced from 
ergosterol by electrical methods. It is a crystalline 
stable substance which can be estimated by biological 
methods and prepared in a standard solution (70). 
The unit is the equivalent in antirachitic 
activity to 0.001 gm of the standard solution, 
chemical methods of estimation not yet being 
relied upon (70). 
Calciferol is related to ten other, or 
possibly more, sterols of plant origin known to 
possess antirachitic activity (71) (72) which 
property can also be produced in cholesterol (73) (74). 
Calciferol is a stable compound having the 
ring structure fractured between C9 and C10 atoms. 
(72) (75). It is claimed that calciferol available 
commercially is freed of toxic bodies and is much 
safer than irradiated ergosterol which may contain 
varying proportions of unwanted products (76) (77) (78). 
PHYSIOLOGY. 
Much of this is still obscure and the most 
recent progress has come from radioactive tracer 
studies in relation to the sterols particularly 
cholesterol. There are normally wide variations in 
the blood levels of Sterols and their determination 
is not at present practicable in the control of 
calciferol therapy. Calciferol influences the 
absorption of phosphorus and calcium from the intestin 
with/ 
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with effects both local and general (79). It has an 
action on the vascular system, the thyroid, 
parathyroids, pituitary and nervous tissue and muscles 
Absorption of calciferol itself from the gut is 
under the influence of bile and in fistula animals 
Greaves (80) has shown that there is little or no 
uptake at all. Diarrhoeal diseases and hypofunction 
of the absorptive surfaces greatly reduce the intake. 
Skin absorption has been demonstrated to be rapid 
from cream bases and toxic levels can be reached 
by this route (81) (82) (83). 
The actions of the antirachitic sterols are 
similar and with purified preparations of irradiated 
ergosterol or with pure calciferol the toxicity 
is low, large doses being well tolerated. (78) (77). 
As an antirachitic compound and with minimum 
Ca and P requirements that of vitamin D2 is estimated 
at. 
300 -400 i.u./day babies. 
400-600 i.u./day adults 
600 -800 i.u./day in pregnancy (84- 
Calciferol has been shown to increase the 
uptake of inorganic phosphorus in bone from recently 
ingested material and to increase the mass of 
reticuloendothelial cells in experimental animals 
(85) (86). 
Other workers have further shown that tissue 
cells can survive toxic levels for a short time 
while at lover levels the tissue 02 utilisation and 
the B.M.R. are increased (87) (83) (88). 
The/ 
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The action is related to that of parathyroid 
hormone there being some interrelationship of 
action since refractory cases of parathyroid tetany 
have been treated successfully with preparations 
of Calciferol (89) 
The trials and usage of the drug in arthritis 
has been extensively studied but the results have 
tended to be disappointing. 
PHARMACOLOGY and THERAtPEUTICS. 
The main use of calciferol has been as an 
antirachitic agent and to promote bone calcification. 
Large doses have been given for arthritis, various 
skin diseases such as acne and psoriasis, and more 
recently for tuberculosis, both of the skin and in 
other organs. 
On the basis of animal experiment Spies (90) 
recommended calciferol as a useful agent to 
promote the calcification of tuberculous lesions and 
there have been other similar attempts to use this 
substance with special regard to calcium metabolism 
(33) (91) (92). The work of Charpy, Dowling and 
Prosser Thomas and others (4) (7) (93). has 
attracted recent attention to the usage of large 
doses over long periods in treating cutaneous 
tuberculosis. 
In resistant rickets very large doses have been 
given or even massive single doses in the prophylaxis 
(94). 
Toxic effects produced by excessive dosage 
lead to death from inanition and cardiac or renal/ 
renal failure conditioned by the period of administra- 
tion and the diet. Alimentary and endocrine disease 
promote the likelihood of these effects as also do 
the use of impure products. The human toxic level 
is assessed by Steck and others (87) at. 
20- 25,000 international units 
kg. body weight per day. 
and this for the ordinary preparations given by mouth. 
The margin of safety is therefore large in 
treating rickets and much smaller in cutaneous 
tuberculosis where the dosage is heavy and prolonged. 
The main toxic effects are .cell damage and a 
tendency to the deposition of calcium and phosphorus 
prinicipally in the blood vessel walls, this process 
being to some extent reversible. The principal 
effects fall on the renal arterioles, the aorta and th 
small vessels of the hypophysis, thyroid, adrenal, 
pancreas and the gut. (95) (96) (87). 
The blood calcium level may be raised, but this 
and that of phosphorus, do not run parallel to the 
harmful effects and therefore can only be used as 
indicators rather than absolute signs of overdosage. 
The blood ionsible calcium fraction is raised with 
large doses. 
The harmful changes may be decreased by vitamin 
A in large doses of 250 to 1000 times the ordinarily 
prophylactic dosage (97). 
The minimum lethal dose experimentally for 
oral preparations in dogs has been estimated by 




13 -20 X 10. ,,u. gms per kilo body weight 
or over a longer period as. 
10041 gms /kilo/ per .day for 100 days. 
Prolonged dosage tends to deplete the Ca and 
P reserves (96) (99) (100) and the toxic effects 
are increased by exposure to ultraviolet light, 
especially in children, presumably by increasing the 
available amount of vitamin through photochemical 
action in the skin (101). 
The toxic tissue changes commence in the blood 
vessels going on to congestive and inflammatory 
reactions which are irreversible and the renal 
damage leadsto nitrogen retention (102). 
Extra calcium durinE the period of vitamin D 
administration tends to raise the Ca and P levels 
in the human and one dose of irradiated ergosterol 
equivalent to 10,000 i.u. vitamin D can do this. 
It has been recommended to control these levels at Ca 
12 mgm per 100 ml. and P 4 mgm per 100 ml during the 
therapeutic period (90). 
The changes in the blood vessels are a 
nonspecific arteriosclerosis commencing at toxic 
levels in experimental animals, with later degeneratio 
and calcification of the elastic coats, especially 
in the kidney, heart, liver, lung and stomach (103) 
(104). 
fats fed experimentally 20 mlgms of irradiated 
ergosterol in alcoholic solution daily for 14 days 
showed vascular calcification and arterial lesions 
similar/ 
similar to Monck °berg's sclerosis, especially in 
the renal vessels. Degenerative changes also occured 
in the spleen and. thymus. Death resulted from 
cardiac failure and the toxicity appeared to be 
increased by a high Ca and low vitamin diet (105) (106) 
(107). 
Calciferol is a potentially dangerous drug 
and should always be administered with caution. 
The toxic manifestations can be mild and a 
careful supervision must be made especially in 
children. 
Recently it has been suggested that cysteine 
can act as an antidote to toxic doses and also can 
inhibit any anti- tuberculous effects (108) (41). 
DOSAGE. 
ows. 
The doses given in rickets may be stated as foil 
Prophylactic (infant) 1,, to 1 
2400 1200 
Therapeutic ( " ) 1 gr to 1 gf 
1200 800 
preparation of potency of 40,000 i.u. per mlgm (109). 
Official Preparations available are :- 
Liq. Calciferolis B.P. add I 
Prophylactic ( Infant) m. 5 -10. 
Therapeutic ( " ) m. 10 -15. 
Liq. Vit D. Conc. B.P. Add II 
0.5 to 3 minims = 250 -- 1.500 i.u. D. 2. 




contained in the B.P. 1932 and in Anderson's work 
(110). 
There are various U.S. standards of potency 
of preparations (111) (109). 
Commercial preparations as tablets or capsules 
are available containing 50,000 i.u. pure calciférol 
in each dose and these are the most convenient form 
of administration in treating tuberculosis cutis. 
Calciferol in oily solution is suitable for oral 
in 
administration and with Vit. A can be given injection 
by the intramuscular route (112). 
Local applications can be made from oily 
solutions of calciferol suspended in a cold cream 
base at the arbitary levels of 1000 i.u. and 5000 i.u. 
per gm, the latter being used in this study. 
In tuberculosis cutis the doses used range from 
50,000 i.u. to 200,000 i.u. per day orally according 
to the age of the patient and the extent of the 
lesions. This can be supplemented by local 
application two or three times daily where the 
the patient 
epidermis is intact and in some cases /continues to 
have ultraviolet irradiation systemically thereby 
increasing the overall total dosage. 
In the absence of accurate criteria of 
dosage those doses used by Dowling can be taken as a 
guide i.e. 150,000 i.u. per day for an adult. These 
fall considerably short of the doses advocated on 
the continent, larger doses being used when results 
are satisfactory but slow, in an attempt to accelerate 
the/ 
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the clinical progress. There appears to be little 
special advantage in giving calcium salts beyond 
preventing any possible demineralisation of the 
skeletal system (114) or in using the drug in 
aicholic solution. 
The drug has been given by the intravenous 
and intraperitonéal routes, experimentally, when it is 
said to be more effective, but the method has many 
dangers. (115). 
Warkany et al (211) studying cases receiving 
large daily doses of vitamin D as calciferol found 
on examination of the blood serum that the blood 
level of the drug rose rapidly to a maximum having 
a subsequent tendency to decrease. After abrupt 
withdrawal of the drug three to six months elapsed 
before the concentration of vitamin D in the bloo1 . 
serum fell to a normal level. The level during 
treatment was found to be roughly proportional to the 
daily dosage. No gross changes were observed in 
the phosphorus fraction. These results support a 
policy of administering calciferol over periods of 
several months followed by rest periods of at least 
4 weeks before further treatment if it is indicated. 
19. 
4. CALCIFEROL A` A CHEMOTHERAPEUTIC AGENT. 
Chemotherapeutic substances may act against 
the tubercle bacillus, the exudate, or the toxins and 
are difficult to evaluate in vivo whatever the action 
in vitro, especially if the action on the natural 
course of the disease is not marked (116). 
Generally anti -tuberculous drugs must be 
tested in man e.g. the use of hydnocarpates in 
lupus (117) and course of the reactions is often 
difficult to assess (118). 
The principles of evaluation are to follow the 
aims and objects of any study by a careful check on 
the organisms, the exudate and the fibrous tissue 
reaction (119). 
The strains and stages of the organisms, the 
effect on susceptible cells, and the ibyiological 
and pathological effects on the host are all factors 
that must be carefully considered in studying any 
anti -microbial agent (120). 
Feldman and Hinshaw (121) have suggested 
criteria for the evaluation of therapeutic agents 
which may be paraphrased as follows: - 
1. The agent is well tolerated. 
2. It should reverse innoculation tuberculosis. 
3. It should render avirulent bacilli in organ 
of predilection. 
4. It should be controlled against a substance 
of known effectiveness such as Fromin. 
5. It should be possible to make a crucial tes 
in selected representative material while 
avoiding fulminating cases. 
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These criteria are exhaustive and extremely 
difficult to attempt to work to. 
In assessing results of therapy, cmnsideration 
must also be given to the amount of tissue destruction 
the amount of resorption, fibrosis, and to calcificatior 
if this last occurs. 
A chemotherapeutic should be able to 
reverse progressive destructive lesions and to 
penetrate tubercles although it may not kill the 
organisms when crippling of the bacterial metabolism 
may be sufficient (122). 
In the past a great many drugs have been tried 
often with disappointing results as in the use of 
gold, despite early apparently favourable indications. 
Some drugs tend to localise in tubercles (123) 
and some can increase the vascularity but no single 
one has been uniformly successful until the advent 
of newer antibiotics such as streptomycin. 
Krause (124) considered that enquiry should be 
made into measures to increase fibrosis, to neutralise 
the toxins of the allergic reaction and to neutralise 
the toxins of the tuberculous foci, possibly non- 
specifically but that a bactericide would be best 
if this could be achieved. 
The lipoids of the tubercle bacillus constitute 
its main defence by being relatively insoluble and 
by forming soaps which inhibit enzymes (125) both of 
which factors are concerned in the chronic exudative 
and proliferative cell responses. This lipoid may be 
diffuse/ 
diffuse in the cell and not confined to the surface 
layers it being shown that water soluble substances 
such as bile and detergents can penetrate and injure 
the bacillus (126) (127) (128). Some synthetic 
detergents are bactericidal with a special action on 
Gram -positive organisms possibly by disorganising the 
resisting cell Lipoids yet this action can be protected 
against by phospholipids (129). 
Linolenic, linoleic and oleic acids normally 
occurring in vivo have these properties which can be 
modified to some degree by the sterols, and linoleic 
acid was found by Boissevain (130) to render the 
organisms non acid fast (59) (60). 
Inhibition of tubercle bacilli has been 
recorded from unsaturated fatty acids with chains of 
15 -18 carbon atoms, fatty acid soaps and free fatty 
acids, and fatty substances derived from fungi. 
(131) (61) (132) (133) (134) (135) (136) (22) (137) 
Crim and Martos found codliver oil to be bacteriostati 
at concentration (138) but this was not borne out 
in the experiments of Stanley (132) and others. 
Dowling et al (2) and Dickinson (139) record 
that calciferol has not been shown to have a direct 
action on tubercle bacilli in vitro nor to have any 
marked effect on the acute disease in experimental 
animals. Raab (140) has claimed tuberculostatic 
properties for vitamin D2 but this observation is as 
yet unconfirmed. Vitamin D 2 enhances the activity 




overall phosphorus metabolism in the chick embryo 
especially in the phosphatide fraction (142) and it is 
logical that this action may extend to the cellular 
metabolic disposal of the lipoid.s of the tubercle 
bacillus. The tuberculous process may thus be 
effectively acted upon by stimulation of the 
reticuloentothelial cells and enhancement of the 
neutralisation of the bacterial products (143) 
constituting a dynamic increase in the body defence 
processes. 
Calciferol because of its lipoid solubility 
should be capable of penetrating tubercles and be able 
to act at the essential site of the reaction to the 
organisms (120). 
No anti- tuberculous specificity can be claimed 
for this drug and more knowledge of the mode of action 
in relation to the individual cells can perhaps come 
from histochemical methods (144) (145) or from 
experiments on tissue cultured with isotopes (142). 
Since the indication of any method of action 
points to an enhancement of the cellular defence 
mechanisms little is to be expected of the drug 
in the more acute forms of the disease when the 
resisting tissues tend to overwhelm c. 
The application of the drug is therefore likely 
to be limited to the less active forms of the disease 
or as an adjuvant to other drugs. 
e 
5 Histology. 
Tuberculosis in the skin has many variations 
anfi forms of which there are direct knowledge, the 
commonest form being Lupus Vulgaris, presenting 
granulomata in the dermis which tend to be grouped 
round the capillaries, epidermal appendages, and the 
lymphatic plexus. Inflammatory and exudative 
changes occur regularly but caseation or necrosis 
is uncommon. Tubercle formation consisting of the 
aggregation of epithelioid cells, giant cells, and 
lymphocytes takes place in the middle and lower 
dermis whence extension toward the.surface leads to 
secondary changes in the epidermis. Some degree of 
fibrous tissue proliferation is usual, especially 
at the periphery of the tubercles and reticulum 
fibres are laid down in some lesions. 
The morphology of the lesions both clinically 
and histologically can be correlated with the 
tuberculin sensitivity of the individual, his immune 
and allergic state, and the prescence of any 
secondary infection (146) (147) (148) (14) (149) (150) 
Tissue allergy and immunity are attributes of mammals 
with tuberculosis which result in a delayed, abortive, 
or more chronic form of the disease, even if it is 
not at present possible to make accurate measurement 
of these powers. 
The clinical form of the disease is the out- 
come of the reaction in vivo between the tubercle 
bacillus and the reactive processes of the host (151) 
(14)/ 
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(14) (152). The histologicR1 picture may, however 
not be identical in sections of diseased areas from 
the same patient since there is considerable variation 
in the degree of local activity. Again the strain 
and type of bacillus may determine the morphology of 
the lesions bT.its virulence or power to provoke 
destructive tissue reactions (154). 
The various forms of skin diseases associated 
with the tubercle bacillus may be seperated by the 
classification of Lewandowsky (153) in which are 
included a number of conditions whose etiology is 
not fully established as being of this origin. 
Lupus vulgaris presents as variable sized 
diseased areas, showing nodules in the dermis 
composed of small tubercles, which progress 
Peripherally with scarring and a tendency to heal at 
the centre. Tubercles in the middle layer of the 
dermis may be discrete or confluent and the collagen 
and elastic tissue usually show some destruction. 
The lesions themselves are avascular but adjacent 
blood vessels are concerned in the disease process. 
The overlying epidermis tends to be thickened, 
to show distortion of the rete pegs, and to be 
hyperkeratotic although the exudate is not usually 
immediately in direct contact with it, there being 
a clear zone in the papillary layer. Gross 
hyperkeratosis, follicular plugging or even necrosis 
of the epidermis may occur with ulcer formation. 
In old cases and those treated with local 
caustics, healing or quiescence may show much 
fibrous/ 
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fibrous tissue formation or old scar tissue. 
Caseation.may be a feature in scrofuloderma when 
bacilli are numerous and the process is more widespread 
involving tissues deeper than the dermis. 
Inflammatory polymorph exudates may be seen 
in forms where the epidermis is breached allowing 
secondary infection to occur. In the tuberculide 
group the lesions are localised and take the form of 
small necrotic areas in the corium extending upwards 
to involve the epidermis and showing a brisk 
inflaìmaatory reaction in the later stages. There 
tends to be much pustular debris and tubercle formation 
is poor perhaps only showing in serial sections. 
Endophlebitis is a feature of the tuberculide while 
in erythema induratum perivascular epitheliod cell 
formation is marked. 
The biological reactions to the tubercle 
acillus and its products follow a constant pattern 
capable of experimental reproduction by both live 
and dead organisms (155) (121) (124) Maximow (156) 
showed that mammalian cells could grow in tissue 
culture along with tubercle bacilli, producing 
typical structural tubercles after a time by the 
formation of epithelioid and phagocytic cells capable 
of some, or partial disintegration of the bacilli. 
ahn (157) demonstrated that histiocytes possessed some 
egree of bacteriostatic action toward engulfed 
tubercle bacilli. 
In vivo the organisms are ingested by mononu- 
1 e ar/ 
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mononuclear phagocytes possibly of vascular origin, 
and are found in the epithelioid cells when these 
are developed, tubercle formation consisting in part 
of the aggregation of these cells without obvious 
vascular supply (158) (124) (159) (160). Stewart et 
al (162) believed the mononuclear leucocyte to be 
capable of disposing of the products, if not being 
the factor lethal to ,the organisms. Failure of the 
bacilli to grow in the cells of the immune animal, 
their destruction, or inhibition, is thus a cellular 
property of the mononuclear phagocyte. 
Tubercle formation as such appears to be 
related to the chemical components of the bacillus 
and particularly to the lipoids, occurs in both 
normal and allergic animals, and seems to be more 
than a reaction of repair yet capable of resolution 
in time (163). Tubercles due to dead bacilli are 
morphologically identical with those caused by live 
organisms, the fundamental type of reaction remaining 
the same and supporting views that the basis of 
virulence is chemical (208). These lesions differ 
only in their failure to progress by multiplication 
of the bacilli (155) (164) (165). Although the 
monocytes vary in appearance and come from the blood 
or local tissues they remain a fundamental part of 
the tubercle, together with histiocytes and fibroblasts* 
In the tuberculous animal the activity of these cells 
is increased according to the degree of reaction 
to the disease. The formation of tubercles is thus th 
essential / 
27. 
basis of the disease process being the outcome of many 
reacting factors important among which are the 
chemical components of the bacillus acting singly 
or as complexes. 
Recent work, by Gerstl (166) (167) (168) (169) 
and others point to the capacity of the cytoplasmic 
enzymes occuring in the monocyte to degrade, or 
dispose of, the lipoid elements derived from tubercle 
bacilli and which have been described as maturation 
factors for the cells of tuberculous tissue. Cellular 
ingestion or disposal of the specific lipoid 
chemical entities such as pthioic acid identified in 
bacilli grown on certain media may explain the 
difficulty noted by Anderson (171) in demonstrating 
these substances in infected tissues. Chemical 
separation of tubercle bacilli in to their component 
elements and the intensive study of the biological 
reactions to these substances has resulted in major 
advances in the knowledge of the disease process. 
(172 -180 incl ) 
Protein, carbohydrate, and lipoid fractions 
have been further refined to obtain in some cases an 
individual chemical compound apparently characteristi- 
cally elaborated by the living bacillus and related 
to its disease producing properties. Much work has 
been done on the details of reactions produced by 
these fractions and it has been shown that the 
phosphatides of the bacillus are responsible for the 
formation of tubercules with epithelioid cells, giant 
cells/ 
28. 
cells, and caseation (172) (181) (182) (183) (170) (13). 
Alcohols and fatty acids peculiar to the organism are 
particularly concerned in this process. Combinations 
of phosphatide with protein havé an enhanced activity 
in provoking experimental reactions (188) (181) and 
constitute antigenic complexes of an ill understood 
nature which may constitute virulence factors for 
the organism (208). The protein fraction experiment- 
ally produces necrosis of collagen and cells leading 
to a polymorphonuclear cell exudate, this reaction 
occurring within a few hours of injection (181) (187). 
Tuberculins are complexes to which the 
reaction in man is usually inflammatory and does not 
histologically resemble the disease (190) but it is 
known that all tuberculins are markedly cytoxic 
toward the cells of tuberculous animals, a property 
which is inherent in these cells. 
Carbohydrate fractions although toxic do not 
appear to cause histological changes that can be 
classified as specifically tuberculous. The wax 
and mycolic acid fractions, however, can be found to 
provoke inflammatory changes which, if not specific 
are considered to contribute to the persistence of 
tuberculous lesions and to the toxicity of the 
organism to mammalian tissues (165) (167) (199). All 
these fractions are difficult to obtain chemically 
pure, even from organisms grown on synthetic media, 
and the linoids cannot be entirely freed of a residue 




In this cdnnection it must be noted that 
Boissevain (192) considered hypersensitiveness to 
dead bacilli to be part of the tissue response and 
that the protein elements of the bacillus manifested 
the greatest biological activity, granulomata 
arising in the prescence of very èmall amounts of 
bacillary material. 
Dienes and Mallory (193) believed that 
granuloma formation developed with the allergic state 
after a lag period of several days, lesions arising 
from a small dose of bacilli being unlikely to be 
caused by the little bacillary lipoid present. 
However the lipoids appear to be the main 
elements concerned in producing the capacity of the 
tubercle bacillus for slow hardy growth in vivo, and 
for a selective inhibitory action on the endocellular 
enzymes of growth and repair, this property being 
more marked in the tuberculous mammal (194) (195). 
The lipoids and perhaps the carbohydrate fraction 
tend to cause prolonged tissue reactions capable of 
slow repair. 
The lipoids of th tubercle bacillus provoke 
the ap)earance of epithelioid cells and the formation 
of tubercles, this action being characteristic but 
not specific, since these cells may be produced by 
other irritants such as silica, lecithin or the 
lipoids of different acid fast bacteria (19) (207). 
The epithelioid cel is a large pale staining 
cell/ 
cell with an oval nucleus and homogeneous cytoplasm 
being considered to represent the later or final 
stage of the reaetion of a mononuclear phagocyte to 
certain stimuli this being bacillary lipoid in 
tuberculous. The cell is capable of survival for up 
to six months in vivo and of some degree of breakdown 
of ingested material by lipases, lecithinases and 
phosphatases. (154) (165) (168) (181) (196). 
Disintegration of the epithelioid cells may 
liberate the irritant more or less intact leading 
to the formation of more such cells and perpetuation 
of the disease process (165) (198). This is the 
mechanism describe.i by Smithburn and Sabin (186) of a 
vicious cycle due to the chemical :Hake up of 
irritant foreign material, namely a series of higher 
fatty acids elaborated by the organisms and of which 
pthioic is the most active (170). This correlation 
of cellular changes and chemical structures resistant 
to breakdown revives the old idea that a major bar to 
healing in tuberculosis in inability to dispose of the 
bacillary lipoids and allows the inference that a 
chemotherapeutic agent can be judged in its capacity 
to alter the morphology of the lesions in the direction 
of resolution. 
Study of this problem has led to the synthesis 
of pthioic acid and similar compounds and their use 
in biological experiments designed to provide informat- 
ion on the action in vivo of the compounds peculiar 
to the tubercle bacillus (200) (201). Synthetic 
Is thioic/ 
30. 
pthioic acid, dehydropthioic acid, and certain other 
fatty acid derivatives have been found capable of 
provoking the histological and blood changes of 
tuberculosis in experimental animals (55) (202) (203), 
and knowledge derived from these sources is applicable 
to the study of the pathological histology of the 
disease. 
Mononuclear and lymphocytic cells are 
associated with regressive lesions and resistance of 
the host, since their cytoplasm has been considered 
a source of antibodies (204) (205) (154) , and this 
property must be considered along with the phagocytic 
powers. 
It would appear, however that the histology 
and certain chemical components of the tubercle 
bacillus have a sufficiently proved relationship 
to enable therapeutically important information to 
be gained from a detailed study of microscopic 
changes in the lesions brought about by treatment. 
31. 
Changes observed in the Histology after treatment with 
Calciferol. 
Initially there appears to be little departure 
from the picture seen prior to treatment but successive 
slides show progress toward healing and,in those cases 
responding clinically;it was noteworthy that this 
healing microscopically lagged behind the macroscopic 
findings. Two cases apparently clinically clear 
showed microscopic tubercles indicating the need 
for adequately prolonged treatment ( Fig. 8). 
The total change to cure or resolution 
appeared as a slow disappearance of the elements 
of the tuberculous exudate, commencing with swelling 
and in some cases vacuolation, of the epithelioid 
cells. 
These cells tended to form less well defined 
tubercles and in later slides to have disappeared or 
to be present only in scattered collections 
surrounded by lymphocytic aggregations ( Fig. 9). 
Lymphocytes and mononuclear cells persisted 
in the areas occupied by the exudate and the final 
stage before clearing was that of a diffuse peri- 
vascular lymphocytic mantling. ( Fig. 2.) 
The vessels of the dermis appeared dilated, 
especially the lymphatics and in some slides so much so 
as to give the impression of new vessel formation. 
This effect was more noticeable in those cases 
responding rapidly to therapy ( Fig. 11). 
The reticular and fibrous tissue of the corium 




of the cellular exudate, there being separation of 
the fibrous connective tissue cells and exposure of 
the subjacent blood vessels (Fig. 11.). 
In the bulk of cases there was do gross 
fibrosis but many slides showed sUfficient increase 
of these elements to be labelled actual laying down 
of new fibrous connective tissue elements, even if thi s 
was not very marked and appeared to be associated with, 
rather than the method of healing ( Fig. 2) 
Some of this collagenous tissue surrounded 
the healing tubercles or in the resolving lesions 
presented as a residuum of the peripheral fibrotic 
reaction concerned in the previously active tubercle. 
No special form of fibrosis was observed 
to result from the exhibition of calciferol in 
either cases responding or resistant to treatment. 
The possibility of reactivation of the lesions 
could only be considered unlikely when the tuberculous 
exudate ha-J . resolved and the sections of skin 
approached the normal histology leaving no trace of 
tuberculous architecture. 
The epidermis showed no special features 
arising from the drug except that where broken 
down healing took place very readily. The overall 
healing of the disease process was slow except in 
a few instances of prompt and rapid progress yet in 
the ordinary responsive case progress took place 
more rapidly than could be expected of any 
spontaneous healing. 
Elastic'=tiaàue visible in the healing lesions 
lesions appeared to be stretched or fragmented in 
the areas previously occupied by a dense exudate. 
In several specimens the epithelioid cells 
became more prominent by recession of the mononuclear 
cell exudate giving rise to an appearance somewhat 
resembling a sarcoid. This structure came as oae 
appearance of healing lupus Tulgaris and can 
occasionally be seen in sections from untreated 
cases. 
The overall picture was found to be a non- 
specific one and not to depart radically from the 
ordinary pattern of healing except in that it 
occurred rapidly and with uniformity in relation 
to calciferol treatment and to the clinical progress. 
No histological calcification was demonstrated, 
even in the occasional area of necrosis or caseation. 
Fat stains did not show any excess or peculiar 
distribution of lipoid material there being no 
readily available histochemical method of demonstrat- 
ing the drug in the tissues and lesions. Response 
appeared more marked in cases of lupus vulgaris of a 
less active type where presumably the disease 




A series of 50 cases was selected from a 
larger bulk of available clinical material to 
contain as many new or untreated patients as -.:possible 
thereby minimising effects due to previous or other 
treatments. 
These were divided into two mains groups viz. 
1. 40 cases of Lupus 1Tul gari s. 
2. 10 cases comprising a number of 
conditions commonly considered to be of tuberculous 
origin. These included tuberculides, erythema 
induratum and sarcoidosis. 
The plan of treatment was based on the 
methods used successfully by Dowling and others, the 
daily dose of calciferol for an adult being in the 
region of 150,000 i.u. daily by mouth supplemented 
by a local application to the diseased areas of 
calciferol in cold cream base 5000 i.u. per gm. 
This latter measure was designed to produce a high 
concentration of the drug at the desired site of 
action. The dosage was recorded in millions of 
international units of the drug given orally 
measured against the number of weeks of administrat- 
ion. To this record was added a note as to the 
concentration of the local application usually 
applied thrice daily. 
The length of treatment was regulated by the 
clinical and histological progress of the individual 
case being usually continued for several weeks 
after/ 
after apparent cure of the areas affected. 
Alternatively some cases had the drug stopped during 
treatment for rest periods of up to four or six 
weeks. No sharp limits were set as to total dosage 
of calciferol or the length of treatment. 
The patient's diet was not altered and the 
practice of prescribing extra calcium salts was 
abandoned as not obviously influencing the course 
of treatment and increasing the likelihood of the 
serum calcium rising to dangerous levels. 
Local destructive treatments were avoided but 
several cases already having ultraviolet light 
therapy continued this satisfactorily while taking 
calciferol, there being no untoward effects from the 
combination. 
Except where refused biopsy of the diseased 
area was made initially to establish the diagnosis, 
at times of significant change in the lesions under 
treatment, and finally to assess the results from 
calciferol therapy. 
The series provided multiple sections from 
112 relevant biopsy specimens thus allowing the 
histologjc to be accurately correlated with the 
clinical state of the lesions. Sample sections 
stained by the Ziehl -Neelsen method failed to 
demonstrate acid fast bacilli in the dermal tissues, 
this being a peculiarity of tuberculous lesions in 
the skin. 
A series of 14 biopsy specimens on examinat- 




organisms yeilded no tubercle bacilli. Each patient 
was checked for active tuberculosis in organs other 
than the skin 'at the time of commencing calciferol 
thera-oy, old healed lesions in lungs or lymph glands 
not being regarded as a bar to treatment. The findin 
are recorded in Table 4. 
Toxic reactions to the dosages of calciferol 
employed were infrequent, none of them causing serious 
upset, and all cases involved were able to continue 
the drug after. a rest period or at a reduced rate of 
dosage. The patient's symptomatology remained the 
earliest manifestation of intolerance although one 
patient reached a level of 18.2. mgm oer 100 ml in 
calcium 
her serum /without any untoward signs. Serum 
s 
calcium estimations were carried out as a precautionary 
measure when large amounts of the drug had been given 
or when any evidence of toxicity was reported. 
The pattern of progress in the responsive 
cases of both groups took the form of a slow recession 
of the lesions leading to the ultimate healing. The 
cases of lupus vulgaris were consistently favourably 
affected only one case failing to benefit ( Table 1). 
Healing was a slow process occurring over periods of 
weeks and accelerated by local applications of the 
drug. 
Clinical observation showed no gross sudden 
changes in the process, this being confirmed by the 
histological changes which in themselves,tended to 
lag behind the gross healing. Microscopic tubercles 
could/ 
37. 
could be demonstrated ( Fig. 8) in early apparent 
clinical cure this revealing the need for adequate 
prolongation of therapy to ensure complete clearing 
of the lesions, and for the histological examination 
'of any suspicious areas in the scar. 
The histological changes brought about by 
calciferol treatment are discussed in Section 3. 
Figures 5 & 6 illustrate a successful 
treatment in a case of lupus vulgaris of 23 years 
standing while the histopathological changes in the 
same case are shown in Figs. 3 & 4. The residual 
healed stage generally presented as a thin pliable 
scar being conditioned by the amount of tissue 
damage prior to ti.eatment. No special type of 
scar formation was observed to arise as a result of 
treatment with calciferol. 
One point noted was that two cases of 
lupus vulgaris both previously treated with tuberculin 
responded rapidly and effectively to calciferol. 
The cases of group 2 varied in their response 
to the drug and the results are tabulated in Table 2. 
The only case of sarcoidosis treated was cleared of 
lesions in 15 weeks. 
All patients in this series presented in a 
satisfactory state of general health and apart from 
the listed toxic manifestations there appeared to be 
no adverse effects due to calciferol. 
38 
33. 
of the cellular exudate, there being separation of 
the fibrous connective tissue cells and exposure of 
the subjacent blood vessels (Fig. 11.). 
In the bulk of cases there was tío gross 
fibrosis but many slides showed siàfficient increase 
of these elements to be labelled actual laying down 
of new fibrous connective tissue elements, even if thi s 
was not very marked and appeared to be associated with, 
rather than the method of healing ( Fig. 2) 
Some of this collagenous tissue surrounded 
the healing tubercles or in the resolving lesions 
presented as a residuum of the peripheral fibrotic 
reaction concerned in the previously active tubercle. 
No special form of fibrosis was observed 
to result from the exhibition of calciferol in 
either cases responding or resistant to treatment. 
The possibility of reactivation of the lesions 
could only be considered unlikely when the tuberculous 
exudate haq resolved and the sections of skin 
approached the normal histology leaving no trace of 
tuberculous architecture. 
The epidermis showed no special features 
arising from the drug except that where broken 
down healing took place very readily. The overall 
healing of the disease process was slow except in 
a few instances of prompt and rapid progress yet in 
the ordinary responsive case progress took place 
more rapidly than could be expected of any 
spontaneous healing. 
Elastic -. tiasue' visible in the healing lesions 
lesions appeared to be stretched or fragmented in 
the areas previously occupied by a dense exudate. 
In several specimens the epithelioid cells 
became more prominent by recession of the mononuclear 
cell exudate giving rise to an appearance somewhat 
resembling a sarcoid. This structure came as one 
appearance of healing lupus vulgaris and can 
occasionally be seen in sections from untreated 
cases. 
The overall picture was found to be a non- 
specific one and not to depart radically from the 
ordinary pattern of healing except in that it 
occurred rapidly and with uniformity in relation 
to calciferol treatment and to the clinical progress. 
No histological calcification was demonstrated, 
even i the occasional area of necrosis or caseation. 
Fat stains did not show any excess or peculiar 
distribution of lipoid material there being no 
readily available histochemical method of demonstrat- 
ing the drug in the tissues and lesions. Response 
appeared more marked in cases of lupus vulgaris of a 
less active type where presumably the disease 




A series of 50 cases was selected from a 
larger bulk of available clinical material to 
contain as many new or untreated patients as :possible 
thereby minimising effects due to previous or other 
treatments. 
These were divided into two mains groups viz. 
1. 40 cases of Lupus Vulgaris. 
2. 10 cases comprising a number of 
conditions commonly considered to be of tuberculous 
origin. These included tuberculides, erythema 
induratum and sarcoidosis. 
The plan of treatment was based on the 
methods ùsed successfully by Dowling and others, the 
daily dose of calciferol for an adult being in the 
region of 150,000 i.u. daily by mouth supplemented 
by a local application to the diseased areas of 
calciferol in cold cream base 5000 i.u. per gm. 
This latter measure was designed to produce a high 
concentration of the drug at the desired site of 
action. The dosage was recorded in millions of 
international units of the drug given orally 
measured against the number of weeks of administrat- 
ion. To this record was added a note as to the 
concentration of the local application usually 
applied thrice daily. 
The length of treatment was regulated by the 
clinical and histological progress of the individual 
case being usually continued for several weeks 
after/ 
after apparent cure of the areas affected. 
Alternatively some cases had the drug stopped during 
treatment for rest periods of up to four or six 
weeks. No sharp limits were set as to total dosage 
of calciferol or the length of treatment. 
The patient's diet was not altered and the 
practice of prescribing extra calcium salts was 
abandoned as not obviously influencing the course 
of treatment and increasing the likelihood of the 
serum calcium rising to dangerous levels. 
Local destructive treatments were avoided but 
several cases already having ultraviolet light 
therapy continued this satisfactorily while taking 
calciferol, there being no untoward effects from the 
combination. 
Except where refused biopsy of the diseased 
area was made initially to establish the diagnosis, 
at times of significant change in the lesions under 
treatment, and finally to assess the results from 
calciferol therapy. 
The series provided multiple sections from 
112 relevant biopsy specimens thus allowing the 
histolo& to be accurately correlated with the 
clinical state of the lesions. Sample sections 
stained by the Ziehl -Neelsen method failed to 
demonstrate acid fast bacilli in the dermal tissues, 
this being a peculiarity of tuberculous lesions in 
the skin. 
A series of 14 biopsy specimens on examinat- 
ion by concentration and cultural methods for 
organisms/ 
36. 
organisms yeilded no tubercle bacilli. Each patient 37. 
was checked for active tuberculosis in organs other 
than the skin 'at the time of commencing calciferol 
thera -uy, old healed lesions in lungs or lymph glands 
not being regarded as a bar to treatment. The findin s 
are recorded in Table 4. 
Toxic reactions to the dosages of calciferol 
employed were infrequent, none of them causing serious 
upset, and all cases involved were able to continue 
the drug after: a rest period or at a reduced rate of 
dosage. The patient's symptomatology remained the 
earliest manifestation of intolerance although one 
patient reached a level of 18.2. mgm per 100 ml in 
calcium 
her serum/without any untoward signs. Serum 
calcium estimations were carried out as a precautionary 
measure when large amounts of the drug had been given 
or when any evidence of toxicity was reported. 
The pattern of progress in the. responsive 
cases of both groups took the form of a slow recession 
of the lesions leading to the ultimate healing. The 
cases of lupus vulgaris were consistently favourably 
affected only one case failing to benefit ( Table 1). 
Healing was a slow process occurring over periods of 
weeks and accelerated by local applications of the 
drug. 
Clinical observation showed no gross sudden 
changes in the process, this being confirmed by the 
histological changes which in themselves,tended to 
lag behind the gross healing. Microscopic tubercles 
could/ 
could be demonstrated ( Fig. 8) in early apparent 
clinical cure thus revealing the need for adequate 
prolongation of therapy to ensure complete clearing 
of the lesions, and for the histological examination 
'of any suspicious areas in the scar.' 
The histological changes brought about by 
calciferol treatment are discussed in Section 3. 
Figures 5 & 6 illustrate a successful 
treatment in a case of lupus vulgaris of 23 years 
standing while the histopathological changes in the 
same case are shown in Figs. 3 & 4. The residual 
healed stage generally presented as a thin pliable 
scar being conditioned by the amount of tissue 
damage prior to t featment. No special type of 
scar formation was observed to arise as a result of 
treatment with calciferol. 
One point noted was that two cases of 
lupus vulgaris both previously treated with tuberculin 
responded rapidly and effectively to calciferol. 
The cases of group 2 varied in their response 
to the drug and the results are tabulated in Table 2. 
The only case of sarcoidosis treated was cleared of 
lesions in 15 weeks. 
All patients in this series presented in a 
satisfactory state of general health and apart from 
the listed toxic manifestations there appeared to be 




Number of cases in the series - 50. 
Type of Disease. Table 1. Group.1 Group 2. 
Lupus Vulgarise 40. 
Tuberculide - papulonecrotic 3, 
Tuberculide - rosacea -like 3. 
Bazin's Disease 1. 
Erythema induratum 2. 
Sarcoidosis 1. 
Table 2. 
Results of Therapy. 
Lupus Vulgarise 
1. Clinical cure, confirmed microscopically 15. 
2. Clinical cure 
3. Improved clinically 









Tuberculide - papulonecrotic. 
1. Clinical cure confirmed. microscopically 1. 
2. Clinical cure 1. 
3. Unimproved 1. 
Total - 3. 
Tuberculide - rosacea-like. 
1. Clinical cure. 2. 
2. Clinical cure with relapse 
and subsequent cure. 1. 
Total - 3 
RESULTS (contd.) 
Group 1 Groin 2 
Erythema Induratu n. 
1. Clinical cure with subsequent relapse 1. 
2. Unaffected 2. 
Sarcoidosis. 
Clinical and histological cure 1. 
Table 3. 





Fall in haemoglobin level. 1. 
Inflammatory reaction in lesions 1. 
Biochemical toxicity 1. 
Total. - 6. 
Table 4. 
Cases showing evidence of tuberculosis in other organs 
Group 1. Group* 
Calcified foci in lung fields 5. 
Suspicious findings " " 2. 1. 
Glandular tuberculosis 
History of Pleurisy 




Lesions involving mucosa 2. 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































H.R. aged 34 Lupus Vul gari s. 
This patient had widespread disease 
present for many years, involving the face, ears, 
neck, trunk and left leg. There was elephantiasis 
of the left lobe of the ear and when first 
reporting he had considerable secondary infection 
of the chest area. Both eyelids showed marked 
oedema and the anterior scalp presented an area 
of alopecia due to the disease. 
There was a'history of "glands in the neck" 
in 1925 from which the lesions had started and 
gradually spread. His father had suffered from 
the same disease over 30 years. An x -ray chest 
was negative, as were W. R. and Kahn tests. 
Two biopsies from different areas showed an 
active tuberculous infiltrate in the dermis with 
oedema and attenuation of the epidermis, there 
was no evidence of healing. 
Calciferol was given at the rate of 150,000 
i.u. daily by mouth and a local application of 
1000 i.u. per gin of cold cream this later being 
increased to 5000 i. u. per gm and applied thrice 
daily. 
At this tide he was prescribed calcium 
lactate gr 10 t. i. d. Two progress biopsies after 
9 million i.u. calciferol plus the local 
application showed no significant change and at 
this 
stage/ 
stage he had made little clinical progress. 
For a time dressings were required to eliminat 
sepsis fr >m necrotic and ulcerated areas on his 
chest but when these healed at about the twelfth il,eek 
of treatment he began to improve rapidly. 
After 21 million i.u. of the drug in twenty 
weeks he was markedly better and the diseased 
areas subsiding. Biopsy at this stage showed a 
considerable change. The epithelioid cell follicles 
were reduced in density and appeared slightly 
oedematous while the lymphocytic infiltration was 
reduced in amount. There were numerous giant cells 
still present and in some areas the fibrous tissue 
tas more marked or increased in amount. The lymph 
channels were dilated and there was a diffuse 
perivascular mononuclear cell infiltrate. Some 
amorphous eosinophilic material was noticed in the 
diseased area but the epidermis was intact and 
appeare ' healthy. 
From this stage he continued to make clinical 
progress and the nodules at the edges of the lesions. 
had subsided. 
It was noted that hair commenced to grow 
again on the scalp in the actual areas of the disease 
which had been entirely denuded of hair. After 
38.5 million i.u. calciferol in 36 weeks mostthe 
areas showed healing and no active nodules could be 
found. There were no toxic signe_, the serum 
calcium being 10.3. mgm per 10 ml. 
At this stage he appeared to be approaching/ 
55. 
56 
approaching a clinical cure and biopsy showed 
disappearance of the tuberculous exudate leaving 
scattered collections of lymphocytes in the dermis 
with a slight increase in the fibroblasts. Fig. 4 
shows a typical section of the healed areas. 
Calciferol was sto, pied after 43 million 
i.u. administered over 40 weeks combined with local 
applications in a cold cream base. There was now no 
evidence of any active disease and the scars were 
sound and pliable. The facial oedema subsided and 
the enlarged ear partly reduced in size to a 
deformed organ produced by previous scarring in 
the area. 
Case 2. 
A.A. Aged 15. Lupus Vulgaris. 
In June 1947 he noticed nodules appearing on 
the left side of the forehead at the site of a "mole" 
present since birth. On examination a series of small 
nodules were visible above the left eyebrow presenting 
the appearance of typical tubercles and these were 
treated with trichloracetic acid locally. X -ray of lung 
fields and a Mantoux test were negative. 
Biopsy in January 1948 was reported as follows: - 
"This section shows a thick nodule in the der,..is 
composed of tuberculoid follicles and many lymphocytes. 
Commencing caseation in some areas but no marked fibro- 
blast proliferation. The epidermis is intact although 
thin and stretched." 
Calciferol was then given to a total of ten 
million i.u. over ten weeks when biopsy of the area then 
showing as a clinical cure revealed that the epithelioi 
cell follicles has disappeared except for several poorl 
formed tubercles and scattered aggregations of lympho- 
cytes. The vessels of the dermis were patent and 
appeared relatively increased in number and there was 
present some young fibrous connective tissue. One area 
showed a small milium surrounded by giant cells. At the 
site of the resolving exudate the collagen fibres were 
separated and a considerable amount of elastic tissue 
was visible. 
Serum calcium at the end of treatment was 10.5 
mlgms. / 
57. 
mlgms. % and he had no toxic manifestations. 
At subsequent review in one month he was stil 





B. O. aged. 9 Lupus Vulgaris. 
Reported with a three months history of an 
eruption on the right side of the nose, inside the 
nose, and on the left side of the neck starting after 
a "gravel rash ". Six years previously he had an 
abscess in the neck and three years previously a 
strumous keratitis. 
On examination the areas presented as 
lupus vulgaris. Biopsy showed multiple tuberculoid 
follicles in the dermis with necrosis and giant cell 
formation. There was little fibrosis and a dense 
infiltrate of lymphocytes and some plasma cells. 
Concentration and culture of biopsy material 
tas negative for organisms. X -ray showed an opaque 
right antrum and an enlarged right hilar lung 
shadow, the former condition clearing after drainage 
followed by a penicillin spray. 
The mantoux test was negative to a dilution 
of 1:10,000 0.T. 
Calciferol was given by mouth supplemented 
after clearing of some secondary infection with 
silver nitrate soaks by local application of calciferol 
1000 i.u. per grm of cold cream. The oral dosage 
totalled 21 million i.u. administered over 20 weeks 
with no toxic manifestations. The neck area had 
almost cleared iì_ a month and at the end of the course 
no nodules were visible when he was assessed as a 
clinical cure. Follow up biopsy showed disappearance 




ilasma and mononuclear cell infiltrate around th.e 
essels. Some areas showed traces of follicular 
architecture in the residual fibroblastic tissue this 
seine sufficient in amount to be called scar formation. 
The epidermis was intact and showed only irregularity 
of the papillae: 
When reviewed in a month and again at two 
months after cessation of treatment he was entirely 
clear of disease, appeared healthy and stated to be 
growing normally. 
Fig. 1. H&Ex90. 
A section showing active Lupus Vulgaris before 
any treatment. The dermis contains tubercle systems 
composed of epithelioid cells, giant cells and lympho- 
cytes. No evidence of healing. 
Fig. 2. H&Ex90. 
A section from an adjacent area of the same case 
after Calciferol treatment with 21 million i.u. in 20 
weeks. The granuloma has resolved leaving a scattered 
mononuclear cell infiltrate and a relative increase of 
fibrous tissue. 
Fig. 3. X 90. 
Section of a case of Lupus Vulgaris after 20 week 
treatment with Calciferol showing commencing resolutio 
of the granuloma. Fig. 5 shows the clinical appearande 
before treatment. The exudate presents a loose appear- 
ance and patent vascular channels are visible. 
Fig. 4. X 90. 
Comparable section from the same case as Fig.3 
after 36 weeks treatment when presenting as a clinical 
ctlre. The clinical appearance at this stage is 
shown in Fig. 6. The only remaining exudate is com- 
posed of scattered mononuclear cells round the vessels 
and hair follicles. This section shows advanced healin 
Fig. 5. 
Clinical appearance of an extensive case of Lupus 
Vulgaris before treatment. The extension of the 
disease to the scalp is unusual and there is hypertrophy 
of the involved left ear. 
Fig. 6. 
Clinical appearance of the same case after 36 
weeks treatment. The growth of hair in the area of 
disease on the scalp is noteworthy. No active 
disease and residual fine scarring. 
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Fig. 7. 
This section shows well advanced resolution in a 
case of Lupus Vulgaris after 70 weeks treatment with 
Calciferol. Clinically no sign of active disease at 
this stage. The dermis contains a healing tubercle 
Et 
with persistence of lymphocytic infiltration but ther 
is no marked change in the fibrous connective tissue. 
Fig. 8. 
Section from a case of Lupus Vulgaris apparently 
clinically cured after 15 million i.u. of Calciferol. 
The dermis contains scattered typical tubercles in- 
dicating persistent activity of the disease at this 
stage of treatment. 
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Fig. 9. x 90. 
This section shows an active Lupus Vulgaris with 
epithelioid and giant cells in the dermis. Untreated 
active disease in the same case as Fig. 10. 
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Fig. 10. x 300. 
A comparable section from the same case as Fig. 9 
after 10 weeks treatment with Calciferol. A higher 
power view to show the granuloma breaking up and 
diminution in the number of epithelioid cells. 
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Fig. 11. x 90. 
Section of untreated active Lupus Vulgaris showing 
the granuloma occupying the middle and deeper layers 
of the dermis. 
Fig. 12 . 
Comparable section from the same case as Fig. 11 
after treatment with Calciferol. The typical tuber- 
culous elements have disappeared leaving a scattered 
mononuclear cell infiltrate. The vascular channels 
are patent and the dermal fibrous tissue is prominent. 
Fig. 13. x 90. 
Section of an 18 day old experimental granuloma 
in guinea -pig skin. Untreated control showing a 
necrotic central area, cells of epithelioid type, many 
mononuclear phagocytes and fibroblasts. 
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Fi$. 14 . (no.16) x 90. 
Section on an 18 day old experimental granuloma 
in gminea-pig skin from an animal receiving 5000 i.u. 
calciferol per kg. daily. The granuloma has largely 
resolved leaving collections of epithelioid cells and 
mononuclear phagocytes in the dermis. 
wig .15 
Untreated active Lupus TTulgaris with ulceration 
in the chest area. 
9. 
Effect of Calciferol on lï-rti_fici.a, Granulomata. 
In.an attempt to support the clinical and 
histological findings resulting from the study of 
human disease in this series it was decided to make 
a preliminary study of the effect of Calciferol on 
artificially created granulomata due to chemical 
entities recognised as being associated with the 
tubercle bacillus. 
Chemical fractions obtained from tubercle 
bacilli cannot readily be obtaine_ in a pure form and 
t was decided to make ul of a chemical imitation of 
he most active granuloma producing compound as yet 
solated from the lipoid moiety; viz pthioic acid. 
The study of the biological activity present 
n synthetic analogues of such active principles has 
my recently received mucü attention although Sabin 
165) experimented with long chain fatty acids resembl- 
ng those found in the tubercle b acil_us. By these 
eans a duplicate form of the disease can be created 
hich is readily available for study and subjecting 
o any treatment under review. There is added advantage 
n the absence of nitrogen from the synthetic molecule 
hereby removing doubts as to the activity of the 
residual quantity of this substance in fatty acids 
Obtained by fractionation of bacilli. 
300 mlgm of synthetic pthioic acid ( T.R.C. 
ubs 270; 3 :12 :15 trimethyl docosanoig acid) was 
indly made available by Dr. Ungar of ihessrs Glaxo. 
his/ 
61. 
This compound was emulsified in 20;á ethanol for 
intracutaneous injection in guinea pig skin in doses 
of 17 mlgms per area. Four guinea pigs received 
three injections each, two animals acting as controls 
while the other two consumed calciferol in oily 
solution in quantities calculated to provide an oral 
dosage of 5,000 i.u. per kilo body weight each day. 
Granulomata resulted in all cases and histological 
study of the lesions was made at, 8, 18 and 35 days. 
No suitable other fatty acid was available as a 
control substance. 
Results. 
Visible granulomata appeared in response to 
the compound in all animals reaching a maximum size 
at about the 7th to 10th day with no gross difference 
between the untreated or treated lesions. Resolution 
was observed to commence in the treated animals being 
macroscopically complete by the 20th to 23rd day 
when gross lesions were still present in the controls. 
All lesions resolved by the 35th day in both treated 
and control animals. 
Sections from specimens taken on the 8th day 
showed. 
(a) control lesions. 
The injection mass surrounded by leucocytic 
debris peripheral to which appeared many mononuclear 
cells resembling epithelioid cells. Many of these 
cells showed vacuoles in the cytoplasm and large vesicu 
lar nuclei. There was no real tubercle formation and 




L122) Treated lesions. 
A similar appearance with aggregations of 
mononuclear phagocytes and polymorphs at the injection 
site. The mononuclear cells resembled epithelioid 
cells but there were no discrete tubercles. 
These sections confirmed the granuloma 
producing properties of the irritant substance but 
showed only a tuberculoid architecture rather than the 
typical lesions of tuberculosis. There was no major 
difference between the treated and untreated granuloma 
at this stage. 
Sections taken on the 18th day showed. 
(a) Control lesions. 
The localised lesions were still present 
as necrotic foci in the dermis with surrounding 
aggregations of cells of the epithelioid type, giant 
cells and some fibroblasts. Many of the cells were 
aggregated but there was no typical tubercle formation 
Fig. 13. 
(b) Treated lesions. 
Well advanced resolution of the experimental 
lesions there being still a few tuberculoid aggregation 
of epithelioid and mononuclear cells in the dermis. 
No caseation and no giant cells were seen Fig. 14. 
It was thus found that calciferól 
expedited resolution of the granulomata this being 
confirmed histologically on all lesions. 
This experimental study limited by the 
amount/ 
amount of available synthetic chemical is not sufficien 
to provide any finite conclusions but has been taken 
to serve as an indication of the experimental results 
to be expected from the use of calciferol on 
artifically created granulomata due to fatty acids 
resembling those of the tubercle bacillus. 
These observations made on guinea pig skin, 
although requiring interpretation in the light of 
species differences, may serve as a basis for a more 
extensive series of controlled studies of the biologica 
properties of pthioic acid and similar compounds and 
the influence of treatment on these. 
The results of calciferol therapy on 
the artifically created granulomata are in accord with 
those observed in the bulk of the human clinical 
material under study and point to the possibility 
of a chemotherapeutic basis of action in stimulation 
of phagocytic cells concerned in the tuberculous 
process. 
This stimulation of the cell cytoplasmic 
activities leading to resolution of the cellular 
elements comprising the exudate can be expected to 
have as an underlying mechanism the speeded up 
breakdown of the irritant compound thus removing the 
stimulus which incites the localisation and 
activities of the phagocytic cells. If it can be 
confirmed that this is the case in respect of a 
chemically known substance represènting the synthetic 
analogue of the most active granuloma producing entity 
found in tubercle bacilli, it indicates that the same/ 
same can occur in diseased areas with visible bacilli 
although perhaps not affecting other than lipoid 
irritant elements. 
It has long been considered that the phagocyte 
can slowly disintegrate such resistant products of 
the tubercle bacillus and facilitation of this pro- 
cess means that it is possible to attack these com- 
pounds when situated within the cells thus representi g 
a chemotherapeutic advance capable of elaboration 
along the lines of specific action. 
The resistance and capacity for slow hardy 
growth in vivo that characterises the tubercle 
bacillus is associated with the chemical structure of 
its products and the relative inability of the 
cellular defenses dispose of these substances so much 
valuable information can come from study of individual 
components obtained by fractionation or synthesis in 
their capacity to produce reactions in mammalian 
tissue. 
DISCUSSION. 
This series of cases confirms that tuberculosis 
cutis can be treated successfully with Calciferol 
though there are occasional lesions which remain un- 
affected or are only slightly altered. 
The effect varies with the type of disease, lupu 
vulgaris being the form most readily benefited. One o 
the series showed minimal improvement after heavy dos- 
age over a prolonged period. Evaluation of the result 
of treatment is difficult but correlation of the 
clinical and histological findings, at intervals, pro- 
vides a definite means of recording progress. Biopsy 
material from the lesions shows a constant pattern of 
microscopic change running parallel to the clinical 
changes but which often lags behind in the later 
stages of resolution. The changes involved in healing 
are slow and evolve over periods of weeks yet with 
definite acceleration produced by local application 
of the drug. 
The morphology of change consists of resolution 
of the granulomata leaving a variable residuum of 
formed fibrous tissue which is visible as a thin pliab 
scar. Macroscopically the lesions appear to subside 
slowly under treatment leaving a nearly normal skin or 
a firm scar, depending on the amount of previous Liss 
destruction or fibrosis. The healed area is often 






associated with calciferol is some swelling of the 
epithelioid cells of the tuberculous follicles and 
some of these cells present a vacuolated cytoplasm. 
Patent vascular channels have been taken to indicate 
increased vascularity of the lesions although only a 
few cases showed reddening or swelling on clinical 
examination, and this in the first few weeks of treat- 
ment. Later the epithelioid cells tend to disappear 
and cannot be seen in sections from clinically healed 
areas. 
The lyrnphocytic and mononuclear cell exudates 
tend to persist longer and to maintain the architectur 
of the tubercle for periods of several weeks before th 
too commences to break up. 
In the later stages of a successful treatment it 
may only be possible to find small focal and peri- 
vascular aggregations of lymphocytes with no indicatio 
of any tubercles. Of course since healing does not 
proceed at a uniform rate in all areas of the lesion, 
tubercles may be microscopically visible at later 
stages in some sections. As will be mentioned later, 
such isolated foci of disease must be watched for in 
assessing the results of treatment and in deciding whe 
to terminate it. The fibrous tissue elements vary in 
amount from case to case and in some appeared to be 
definitely increased. In this connection it is 
necessary to consider the extent of previous scarring 
and the tendency of the disease to heal with fibrosis. 
No special or peculiar form of fibrous tissue formatio 
could/ 
68 
could be found to arise from the exhibition of calcite ol. 
In many sections the elastic tissue showed disruption 
or fragmentation which was revealed as the exudate 
subsided. Yi notable number of capillary vessels relat: d 
to the tubercle systems in the dermis also became mani est 
as the cellular elements of the tubercles decreased in 
quantity the indication being that these existed befor 
although they were not readily visible in sections. 
The overall changes resulting from the method 
of treatment may be summarised as consisting of resolu 
tion of the dermal tubercles and disappearance of the 
cellular exudate leaving a variable degree of fibrosis 
and scar tissue. 
These changes are not specific since they may 
also follow treatment with ultraviolet irradiation or 
even represent the course of events in spontaneous 
healing of a lesion. The significance lies in the 
uniformity with which these effects can be brought 
about by calciferol and in the observation that healing 
takes place by involution and disappearance of cellula 
elements which can be shown experimentally to arise in 
response to the tubercle bacillus and its products. 
Epithelioid cells can arise in other circumstances 
simulating the lesions of tuberculosis as in those due 
to silica but the cases in this series were selected 
as being of tuberculous origin. It is known that 
phagocytic cells ingest tubercle bacilli yet may 
fail 
to destroy them or their products with resulting 
form- 
ation/ 
formation of epithelioid cells and tubercle formation, 
so it becomes possible to infer that a substance pro- 
moting resolution of tubercles has enhanced the cyto- 
plasmic activities which are concerned in the disposal 
of these irritants. 
The inference that calciferol can increase the 
powers of phagocytes to deal with the organismal pro- 
ducts of the tubercle bacillus is supported by the 
effect described on granulomata arising from the synthe 
analogues of phthioic acid. In this connection the 
literature contains observations of the power of 
calciferol to stimulate leucocytes (171), to increase 
tissue metabolism (141) and to increase the cellular 
phosphatide turnover in mamnalian tissue (142). 
Such a mode of action would also explain the 
recorded lack of direct effect against the tubercle 
bacillus in vitro, despite persistent reports of bene- 
ficial effects derived from calciferol in vivo. 
Tuberculosis in the skin is a relatively much 
less active process than in other tissues and it is 
probable that the production of bacterial irritants is 
small so enhanced powers of the phagocytes become capab 
of dealing with these substances and this may also occu 
in some forms of tuberculous adenitis. 
The conflicting and generally negative reports o 
the use of calciferol in pulmonary tuberculosis may wel 
arise from conditions of more ready bacterial prolifer- 







overwhelmed. Perpetuation of the disease process in 
the skin can be presumed to be due to the chemical 
resistance to cellular disintegration of the peculiar 
fatty acids of the tubercle bacillus and which, if 
released by the disintegration of the cells, are capable 
of inciting the production of further epithelioid cells 
since it may be taken that these latter arise pre- 
eminently in response to lipoid irritants. 
The effect of calciferol on this biological 
reaction patently arises from alterations in the tissue 
chemistry when penetration of the tubercles and cells 
can be inferred from the resemblance to cholesterol 
which is itself known to accumulate in tuberculous foci. 
There is no evidence that calcification was the 
mechanism of action and it was not observed in any section 
from this series of cases. Caseation and necrosis are 
uncommon in the skin so there is little material prone 
to calcify in contrast to the lesions in acute disease 
of experimental animals when considerable local calcific- 
ation may occur. Tomlinson (167) observed that the 
local tissue calcium content was raised in lupus vulgaris 
treated with calciferol but that this occurred in a 
form not readily demonstrable by histological methods. 
Calciferol acting on the host's powers to degrad 
or dispose of tubercle -producing substances need not 
necessarily affect the immunity or sensitivity levels 
with the result that on cessation of administration 
any residual foci may tend to reproduce the lesions 
and/ 
and lead to reactivation of the disease. 
Therapeutic response to the drug is principally 
observed in individuals already possessing a high level 
of resistance indicating the limited results to be ex- 
pected of the present form and dosage. It is thus 
possible that a derivative or a related sterol may 
possess a more significant anti -tuberculous action by 
means of chemical effects on the phagocytic cells con- 
taining the bacillus or its products. Alternatively the 
best use of calciferol may be as an adjuvant to some 
direct bactericidal agent or even to one of the forms 
of tuberculin since it has been shown that inhibition of 
the tubercle bacillus is a cellular property of the 
mononuclear phagocytes of immune animals (205). A 
potential source of further information on the properties 
of the drug is study of the effect on granulomata 
created by fractions of the tubercle bacillus, or their 
synthetic analogues and having the special object in vi w 
of determining the reactions of the phagocytic cells by 
histological methods which enable ready evaluation of 
the structural changes. 
The effects of this and similar chemicals on the 
cytoplasmic activities of the phagocytic cells is a 
field worthy of further study and development,especially 
by histochemical investigation of the enzyme systems. 
Regarding the clinical aspects of the treatment, 
it was found that healing was slow; that it reached 
completion in fifteen cases of lupus 
vulgaris; and was 
proceeding satisfactorily in twenty -four 




time of assessment. 
The slow metabolism and healing in skin tissues 
tends to prolong any treatment and to render difficult 
comparison with tuberculosis in other organs. Long 
follow -up periods are necessary to determine any possible 
recurrence arising from microscopic foci of disease 
persisting in parts of the lesions. Serial sections of 
specimens from the lesions confirm the observations of 
F reudenthal (12) that small granulomata tend to persist 
and to produce subsequent relapse. 
Fig. 8 illustrates such a lesion in a case free 
of visible active disease and under consideration for 
cessation of treatment. This demonstrates the value of 
histological assessment of cure and the need for pro- 
longing therapy after apparent clinical cure. In this 
study a case was regarded as representing a clinical 
cure when no visible disease could be found and as a 
cure, at least of the skin lesions, when representative 
sections showed no microscopic evidence of tuberculosis. 
These terms are therefore relative and subject to the 
results of periodic review of the treated cases. 
The cases of group2 represent a number of less 
well -defined entities yielding variable results to 
treatment, two cases of erythema induratum being com- 
pletely unaffected. The single case of sarcoidosis 
showed continuous benefit and subsidence of 
the lesions. 
It is possible that here again calciferol 
enables the 
epithelioid type cell to deal more adequately 
with the 
substances provoking its occurrence. 
I n/ 
"7 7 
In considering dosage it has to be remembered 
that calciferol has dangerous potentialities and that 
the optimum results come from doses which may give rise 
to toxic effects. 
On the duration and intensity of therapy depends 
the likelihood of these effects which must be guarded 
against by a watch for symptoms such as nausea, headacíie, 
gastrointestinal upset, or polyuria and by estimations 
of the serum calcium level. The average case however 
shows few if any untoward effects. Doses of 100,000 i.u. 
to 200,000 i.u. of calciferol daily are well tolerated 
and can be safely combined with local application or 
ultraviolet light therapy. Only six cases had toxic 
manifestations and none of these had any serious dis- 
ability. 
Local application of the drug allows of higher 
concentration on the diseased area and is useful both 
on the intact surface and in cases with ulceration pro- 
vided there is no gross secondary infection. The 
strength of local applications can be arbitrarily set 
at 5000 i.u. of calciferol in a basis of cold cream and 
the systematic use of this preparation is capable of 
accelerating healing. 
The period of administration usually extends over 
several months for the average case and 
is best measured 
by the clinical progress and by biopsy of 
the lesions. 
Clinical resolution must be confirmed 
histologically 
and this examination repeated on 
any suspected areas of 
recurrence prior to termination 
of treatment. No 
accurate/ 
7Q 
accurate limit can be set as a maximum safe length of 
treatment but cases in this series show no ill- effects 
after more than one year on the drug. One case showed 
a dangerous level of the serum calcium after 70 weeks 
treatment and a second a fall in the haemoglobin to 
55% at the end of 100 weeks on the drug although it was 
noaclear that this caused the anaemia. 
A satisfactory policy is to prescribe continuous 
treatment and to review critically the progress at the 
end of each four week period with an assessment of the 
at the end of three months and six months. This 
enables one to make any alterations in dosage and to 
keep an accurate check on the effects of treatment on 
the lesions. 
When an apparent cure results, a three monthly 
periodic review is necessary to examine the healed 
areas and to make histological study of any suspected 
area of disease. 
The duration of dosage required to achieve optimum 
results is not finite but varies with each individual 
case, guidance being best derived from progress while 
watching for any sign of toxicity. 
This study of calciferol therapy shows that the 
drug falls short of the criteria for a successful 
chemotherapeutic agent but is of real value in tuber- 
culosis cutis. Apparent clinical and histological 
cures of the disease assessed after short follow -up 
periods may not appear so favourable on longer term 
review when relapses should be manifest. 
In/ 
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In conclusion it may bè said that this study 
concerns some features of only one form of tuberculosis 
and that the results must be interpreted with caution., 
An attempt has however been possible to take advantage 
of the readiness with which even small changes in the 
lesions can be inspected and subjected to microscopic 
scrutiny, thereby reducing the complexities of assess- 
ing chemotherapy in this disease, and with the added 
benefit of pathological material from humeri sources. 
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CONCLUSIONS. 
1. Calciferol treatment produced clinical and histological 
healing in fifteen out of forty cases of tuberculosis 
cutis (lupus vulgaris). 
2. Effective therapeutic action was found on the tubercle 
systems of Lupus Vulgaris. 
3. The findings tend to indicate that this action is non- 
specific. 
4. Histopathological assay of the disease at intervals 
during treatment revealed the structural changes involved 
in the chemotherapeutic effect of the drug. 
5. Histologically the action of calciferol on tuberculosis 
cutis is found to be resolution of the tubercle systems, 
starting with the epithelioid cells and followed by the 
lymphocytic and mononuclear cell exudates, leaving a 
variable residuum of fibrous connective tissue. 
6. The findings support the view that the mode of action 
of calciferol is by promoting the cellular metabolic 
disposal of irritant substances arising from tubercle 
bacilli; that it occurs in the cytoplasm of the phago- 
cytic cells; and that this is adequate only in dealing 
with small quantities of such substances. 
7. No special or characteristic type of fibrosis follows 
calciferol therapy but there is no apparent resolution 
of fibrous or scar tissue already created by the disease 
process. 
8. The disease is capable of reactivation from persistent 
microscopic/ 
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microscopic foci remaining after apparent clinical 
healing if treatment is insufficiently prolonged. It is 
necessary to continue treatment or to give a repeat 
course of the drug to ensure against such relapses. 
9. Doses of 150,000 i.u. daily of calciferol are well 
tolerated by the average case and can be safely com- 
bined with ultraviolet light irradiation without causing 
toxic effects. 
10 Local application of calciferol to the diseased area in 
Ì 
a concentration of 5000 i.u. per gm. of cold cream base 
is found to accelerate clinical healing in lupus vulgaris. 
11 In Lupus Vulgaris the period of administration is 
primarily governed by the clinical state of the patient. 
In the absence of any toxic manifestations the average 
case may continue treatment for 6 -12 months by which 
time any significant benefit should have resulted. 
12! Confirmation of healing is made by histopathological 
examination of biopsy material from the lesions. 
13. All treated cases should be reviewed at intervals of 
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